Bank Of America Corp Salarius Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.34 - $0.54 $8 - $14	-26 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.49 - $1.01 $12 - $26	26 New	26 $0
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.15 $14 - $20	-18 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$1.02 - $1.52 $18 - $27	18 New	18 $0

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $3.52M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.